Trinity Biotech | TRIB - Operating Profit


Trinity Biotech reported $-509K in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Abbott USD 1.85B 399M Mar/2026
Bayer EUR 3.53B 2.42B Mar/2026
Bio-Rad Laboratories USD 53.9M 10M Dec/2025
EDAP TMS EUR -4.92M 843K Sep/2025
J&J USD 6.62B 1.03B Mar/2026
Mesa Laboratories USD 5.78M 2.27M Dec/2024
OraSure Technologies USD -13.59M 2.13M Dec/2025
Plus Therapeutics USD -5.74M 1.26M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Siemens EUR 2.57B 3M Dec/2025
Surmodics USD 58K 5.7M Jun/2025
Thermo Fisher Scientific USD 1.91B 389M Mar/2026
Tosoh JPY 25.64B 486M Mar/2026
Trinity Biotech USD -509K 6.27M Sep/2025
Veracyte USD 19.08M 5.55M Mar/2026